Lambert-eaton myasthenic syndrome: a case report and review of the literature.
Lambert-Eaton myasthenic syndrome (LEMS) is a type of paraneoplastic syndrome that may initially manifest with weakness and gait abnormalities. These symptoms may precede the diagnosis of malignancy by months or years, and morbidity and mortality may be significantly affected by early detection of the malignancy. A case report and review of the diagnosis, management, and treatment of these syndromes are presented, with particular emphasis on the rehabilitation management of these patients, often overlooked in medical treatment.
Lin
Julie T
JT
Physiatry Service, Hospital for Special Surgery, and Department of Rehabilitation Medicine, The New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York 10021, USA. j_lin4@yahoo.com
Lachmann
Elisabeth
E
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D002945:Cisplatin / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015624:Lambert-Eaton Myasthenic Syndrome / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D008175:Lung Neoplasms / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D012128:Respiratory Distress Syndrome / Q000209:etiology
D000970:Antineoplastic Agents; D005047:Etoposide; D002945:Cisplatin